V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167984 | 20064029 | 1.76 | 87 | Neo-adjuvant (N) | 2018-01-22 | 2018-01-30 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100846964 |
| 20167985 | 20064030 | 1.75 | 67.4 | Neo-adjuvant (N) | 2017-07-31 | 2017-08-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100939806 |
| 20167986 | 20064031 | 1.76 | 86 | Palliative (P) | 2016-10-17 | 2016-10-24 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100495504 |
| 20167988 | 20064032 | 1.69 | 48.7 | Palliative (P) | 2017-12-13 | 2018-01-05 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100578821 |
| 20167989 | 20064033 | 1.5 | 61.6 | Adjuvant (A) | 2018-04-05 | 2018-04-19 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100604046 |
| 20167991 | 20064034 | 1.62 | 111 | Palliative (P) | 2018-02-11 | 2018-02-11 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100661990 |
| 20167996 | 20064035 | 1.62 | 62.3 | 03 | 2018-08-18 | 2018-08-31 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100420930 |
| 20168003 | 20064036 | null | null | Adjuvant (A) | 2018-07-20 | 2018-08-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100351118 |
| 20168005 | 20064037 | 1.69 | 62.85 | Adjuvant (A) | 2017-06-30 | 2017-07-14 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100548915 |
| 20168006 | 20064038 | 1.57 | 64.2 | Neo-adjuvant (N) | 2019-10-06 | 2019-10-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101737811 |
| 20168007 | 20064039 | 1.62 | 68 | Adjuvant (A) | 2016-04-01 | 2016-04-16 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100142924 |
| 20168013 | 20064040 | null | null | Palliative (P) | 2007-07-21 | 2016-06-16 | ECX | 02 | N | FLUOROURACIL | 100025619 |
| 20168014 | 20064041 | 1.55 | 99.4 | Palliative (P) | 2017-02-22 | 2017-03-12 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101800691 |
| 20168016 | 20064042 | 1.76 | 43.2 | null | 2016-06-02 | 2016-07-13 | Fluorouricil + Folonic Acid (MdG) | 02 | Y | FLUOROURACIL | 100120969 |
| 20168019 | 20064043 | 1.78 | 87.8 | Curative (C) | 2018-11-01 | 2018-11-14 | FLUOROURACIL | N | N | FLUOROURACIL | 101469184 |
| 20168020 | 20064044 | 1.51 | 62.1 | Neo-adjuvant (N) | 2018-05-25 | 2018-05-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101039691 |
| 20168023 | 20064045 | 1.85 | 106.2 | Palliative (P) | 2018-10-12 | 2018-10-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100143766 |
| 20168026 | 20064046 | 1.56 | 67.2 | Adjuvant (A) | 2016-11-26 | 2016-12-06 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 101383095 |
| 20168030 | 20064047 | 1.75 | 90.1 | Curative (C) | 2017-01-01 | 2017-01-18 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100324206 |
| 20168032 | 20064048 | 1.54 | 94 | Neo-adjuvant (N) | 2016-10-26 | 2016-11-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100015522 |
| 20168033 | 20064049 | 1.66 | 90.4 | null | 2016-05-26 | 2016-05-31 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100233461 |
| 20168039 | 20064050 | 1.62 | 68.8 | Neo-adjuvant (N) | 2018-09-12 | 2018-09-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101423368 |
| 20168040 | 20064051 | 1.8 | 87 | Palliative (P) | 2018-10-20 | 2018-10-20 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100229193 |
| 20168041 | 20064052 | 1.82 | 59.7 | Adjuvant (A) | 2017-04-08 | 2017-04-14 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100776405 |
| 20168044 | 20064053 | 1.58 | 80.85 | Adjuvant (A) | null | 2018-05-18 | FLUOROURACIL | N | N | FLUOROURACIL | 101616610 |
| 20168045 | 20064054 | 1.7 | 39.8 | Adjuvant (A) | 2016-04-21 | 2016-04-30 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100759616 |
| 20168047 | 20064055 | 1.7 | 83.6 | Curative (C) | 2016-04-30 | 2016-05-11 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100666826 |
| 20168053 | 20064056 | 1.59 | 64 | Adjuvant (A) | 2016-11-15 | 2016-11-18 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100766249 |
| 20168060 | 20064057 | 1.82 | 69.2 | Palliative (P) | 2016-10-31 | 2016-11-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100041568 |
| 20168061 | 20064058 | 1.69 | 85.2 | Adjuvant (A) | 2018-06-12 | 2018-06-12 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101649865 |
| 20168063 | 20064059 | null | null | Adjuvant (A) | 2018-02-02 | 2018-02-03 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101544526 |
| 20168065 | 20064060 | null | null | Adjuvant (A) | 2016-08-13 | 2016-08-25 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100309916 |
| 20168083 | 20064061 | 1.71 | 70.5 | Palliative (P) | 2017-10-01 | 2017-10-02 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100217154 |
| 20168084 | 20064062 | 1.85 | 65 | Neo-adjuvant (N) | 2020-04-27 | 2020-05-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100092640 |
| 20168088 | 20064063 | 1.68 | 69.3 | Neo-adjuvant (N) | 2017-11-05 | 2017-11-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100387443 |
| 20168099 | 20064064 | 1.72 | 75.9 | Neo-adjuvant (N) | 2019-06-19 | 2019-06-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101416054 |
| 20168104 | 20064065 | 1.54 | 55 | Neo-adjuvant (N) | 2016-05-29 | 2016-06-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101337560 |
| 20168120 | 20064066 | 1.7 | 108 | Neo-adjuvant (N) | 2018-05-30 | 2018-06-05 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100787253 |
| 20168131 | 20064067 | 1.47 | 106 | Adjuvant (A) | 2017-10-22 | 2017-10-22 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101044461 |
| 20168132 | 20064068 | 1.78 | 85.3 | Neo-adjuvant (N) | 2019-03-21 | 2019-04-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101231132 |
| 20168145 | 20064069 | 1.55 | 74.15 | Neo-adjuvant (N) | 2019-05-16 | 2019-05-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100840299 |
| 20168146 | 20064070 | 1.64 | 50.4 | Curative (C) | 2018-09-29 | 2018-09-29 | Fluorouricil + Folonic Acid (MdG) | 02 | null | FLUOROURACIL | 101311327 |
| 20168150 | 20064071 | 1.65 | 60.2 | Neo-adjuvant (N) | 2019-10-19 | 2019-10-26 | ECX | 02 | N | FLUOROURACIL | 100723809 |
| 20168151 | 20064072 | 1.76 | 79.4 | Adjuvant (A) | 2017-04-06 | 2017-04-06 | Fluorouracil + Folinic Acid Weekly | 2 | N | FLUOROURACIL | 101076627 |
| 20168152 | 20064073 | 1.8 | 61.6 | Palliative (P) | 2019-09-20 | 2019-09-20 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100915715 |
| 20168153 | 20064074 | 1.54 | 62.7 | Neo-adjuvant (N) | 2019-01-04 | 2019-01-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100647371 |
| 20168159 | 20064075 | 1.65 | 63.9 | Palliative (P) | 2017-08-20 | 2017-09-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101066181 |
| 20168169 | 20064076 | 1.7 | 41.5 | Neo-adjuvant (N) | 2018-07-25 | 2018-07-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101608112 |
| 20168176 | 20064077 | 1.55 | 92.5 | Curative (C) | 2018-09-09 | 2018-09-09 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101235613 |
| 20168177 | 20064078 | 1.64 | 73.2 | Neo-adjuvant (N) | 2020-01-01 | 2020-01-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101663836 |